Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- ChecktodayChange DetectedThe revision tag in the page footer was updated from v3.5.4 to v3.5.5, indicating a minor software update to the page.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedA clinical study report synopsis, sponsor-related items (AbbVie), and a new 'Helpful Links Provided by AbbVie' section were added, and the page revision was updated to v3.5.4.SummaryDifference0.2%

- Check43 days agoChange DetectedThe ClinicalTrials.gov page’s footer version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No changes to the page content or clinical information are indicated.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.